XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating Activities    
Net income $ 201,639 $ 208,233
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation & amortization 14,714 14,776
(Increase) decrease in value of equity securities (729) 10,625
Amortization of securities, net 7,572 8,219
Accretion of purchased loans (4,645) (5,832)
Share-based compensation 4,223 4,841
Gain on assets (2,364) (1,382)
Provision for credit losses on loans 13,500 3,500
Recovery of credit losses on unfunded commitments (1,000) 0
Provision for credit losses on investment securities 0 1,683
Deferred income tax effect 3,640 (1,255)
Increase in cash value of life insurance (2,474) (2,315)
Originations of mortgage loans held for sale (289,488) (212,931)
Proceeds from sales of mortgage loans held for sale 302,018 166,921
Changes in assets and liabilities:    
Accrued interest receivable (2,018) 2,133
Other assets (24,022) (8,709)
Accrued interest payable and other liabilities 36,358 (23,451)
Net cash provided by operating activities 256,924 165,056
Investing Activities    
Net decrease (increase) in federal funds sold 5,100 (1,550)
Net (increase) decrease in loans (385,557) 270,329
Purchases of investment securities – available-for-sale (5,100) (3,933)
Proceeds from maturities of investment securities – available-for-sale 146,479 407,431
Proceeds from maturities of investment securities – held-to-maturity 3,239 2,658
Proceeds from sales of equity securities 0 1,522
Purchase of other investments (1,858) (134)
Proceeds from foreclosed assets held for sale 938 477
Proceeds from sale of SBA loans 3,586 2,337
Purchases of premises and equipment (11,902) (9,511)
Proceeds from sales of premises and equipment 12,829 8,081
(Purchase of) return of investment on cash value of life insurance, net (1,218) 2,909
Net cash (used in) provided by investing activities (233,464) 680,616
Financing Activities    
Net increase (decrease) in deposits 168,092 (941,892)
Net (decrease) increase in securities sold under agreements to repurchase (4,089) 29,203
Decrease in FHLB and other borrowed funds (1,400,250) 0
Increase in FHLB and other borrowed funds 1,400,000 51,550
Proceeds from exercise of stock options, net 670 361
Repurchase of common stock (57,041) (25,349)
Dividends paid on common stock (72,339) (73,144)
Net cash provided by (used in) financing activities 35,043 (959,271)
Net change in cash and cash equivalents 58,503 (113,599)
Cash and cash equivalents – beginning of year 1,000,213 724,790
Cash and cash equivalents – end of period $ 1,058,716 $ 611,191